MAS+ and HeiQ announce a partnership in producing functional personal protective equipment (PPE) integrating HeiQ’s latest antiviral textile technology
Southeast Asia’s largest apparel and textile design-to-delivery solutions provider MAS+ created a range of functional and comfortable PPE products that integrate HeiQ Viroblock NPJ03.
This initiative is an effort to mitigate the spread of the COVID-19 and other hospital infections. This revolutionary textile treatment has shown a 99.99% reduction of the SARS-CoV-2 virus in laboratory tests conducted by the Peter Doherty Institute for Infection and Immunity in Melbourne, Australia.
The wash-durable textile treatment will turn into a substantial addition to MAS+’s latest range of reusable medical supplies and PPE.
Ranil Vitarana the Chief Innovation Officer for MAS Holdings, stated, “As a company led by innovation, we found HeiQ to be an equally innovative organization. We have been partnering with them for the past 5 years to bring innovative solutions to the market. This is a good example of the activeness of HeiQ.”
Through various combinations of innovation and decades of manufacturing know-how, MAS+ aims to protect frontline workers and reduce infection costs. The manufacturing capabilities MAS with 53 factories across 16 countries allows the design and delivery of customized PPE within 4 weeks, offering product development and rapid prototyping while leveraging their global supply chain.
Co-founder and group CEO of HeiQ, Carlo Centonze said, “HeiQ and MAS have been an innovation partner for 5 years now. The HeiQ team expressly enjoy working with MAS Twinery for that they have an innovative spirit like a start-up. Proud to bring antiviral PPEs treated with HeiQ Viroblock together to the market.”
“We have been engaged closely with teams in multiple different business units under the MAS umbrella. It is always illuminating to work with these teams they use the concept of innovation as a challenge, to both build on and execute projects which impact positively on our stakeholders,” said Musa Rabin, VP HeiQ Brandforce South Asia.
“Even over the past few months where the pandemic has re-shaped how we approach innovation, the teams at MAS have risen to challenge of re-tooling themselves to offer the best possible technologically driven products to help with the goal reducing the risk of transmission in society at large as well as protecting our frontline warriors, globally. HeiQ is glad to partner with MAS help with this goal and eager to support through the onboarding of HeiQ Viroblock technology,” added Rabin.
